Acyclovir Cream
NDC Package 62332-423-05
Package Information
Acyclovir cream is a herpes simplex virus (HSV) deoxynucleoside analogue DNA polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. This formulation utilizes a cream delivery system. Marketed by Alembic Pharmaceuticals Inc., this product is identified by NDC 62332-423 and is authorized under FDA application ANDA212361.
Identification & Billing
- RxCUI: 141859 - acyclovir 5 % Topical Cream
- RxCUI: 141859 - acyclovir 50 MG/ML Topical Cream
- RxCUI: 141859 - acycycloguanosine 50 MG/ML Topical Cream
Clinical Specifications
- DNA Polymerase Inhibitors - [MoA] (Mechanism of Action)
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Nucleoside Analog - [EXT]
Regulatory & Marketing
Hierarchy Structure
- 62332 - Alembic Pharmaceuticals Inc.
- 62332-423 - Acyclovir
- 62332-423-05 - 1 TUBE in 1 CARTON / 5 g in 1 TUBE
- 62332-423 - Acyclovir
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62332-423-05 identifies a specific commercial package of 1 tube in 1 carton / 5 g in 1 tube of Acyclovir, a human prescription drug labeled by Alembic Pharmaceuticals Inc.. This cream is formulated for topical use and contains acyclovir as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alembic Pharmaceuticals Inc. on November 27, 2023. The current certification is valid through December 31, 2027.
How is this Alembic Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62332042305. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.